DAX: Ongoing trouble with Greece

At the beginning of this week the development in Greece was the main negative factor for the European financial markets.

bg_german_stock_exchange_1550419
Source: Bloomberg

As a result the German stock market has been testing the Fibonacci retracement (23.6 per cent) at 11,695 and the 55 days exponential moving average (EMA) at 11,667. So far with success.

The crisis in the Mediterranean nation would be the main issue for the coming days and weeks. And therefore a further test of the mentioned supports is likely. Below this price levels the DAX would generate a short-term sell signal. In this case the trend line at 11,454/11,467 could be achieved.

Currently the technical situation is neutral. Only above the highs at 11,891/11,893 the German stock market could continue the upward movement. The psychological level at 12,000 would be the first target price. Above this level we see further upward potential to the highs from April 2015 at 12,400.

German stock markets DAX on daily basis

DEM_Daxtageschart28052015
IG Charts

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.